Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 484
Book Description
S. 2071: to amend the Public Health Service Act to provide for the establishment of national research awards ; S. 2072: to amend the Public Health Service Act to assure maximum protection for human subjects of biomedical and behavioral research ; H.R. 7724: to amend the Public Health Service Act to establish a national program of biomedical research fellowships, traineeships, and training to assure the continued excellence of biomedical research in the United States, and for other purposes, and related bills
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 484
Book Description
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 484
Book Description
Quality of Health Care--human Experimentation, 1973: S.2071 S.2072 H.R.7724 Apr. 30 June 28 to 29 July 10 1973
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 484
Book Description
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 484
Book Description
S. 2071: to amend the Public Health Service Act to provide for the establishment of national research awards ; S. 2072: to amend the Public Health Service Act to assure maximum protection for human subjects of biomedical and behavioral research ; H.R. 7724: to amend the Public Health Service Act to establish a national program of biomedical research fellowships, traineeships, and training to assure the continued excellence of biomedical research in the United States, and for other purposes, and related bills
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 496
Book Description
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 496
Book Description
Quality of Health Care--human Experimentation, 1973
Author: United States. Congress. Senate. Labor and Public Welfare
Publisher:
ISBN:
Category :
Languages : en
Pages : 1206
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 1206
Book Description
Quality of Health Care--human Experimentation, 1973
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 896
Book Description
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 896
Book Description
Quality of Health Care--human Experimentation, 1973. Hearings, Ninety-third Congress, First Session, on S. 974 ... S. 878 ... S.J. Res. 71 ..
Author: United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 1360
Book Description
Publisher:
ISBN:
Category : Human experimentation in medicine
Languages : en
Pages : 1360
Book Description
Hearings, Reports and Prints of the Senate Committee on Labor and Public Welfare
Author: United States. Congress. Senate. Committee on Labor and Public Welfare
Publisher:
ISBN:
Category : Labor policy
Languages : en
Pages : 1364
Book Description
Publisher:
ISBN:
Category : Labor policy
Languages : en
Pages : 1364
Book Description
Public Affairs Information Service Bulletin
Author:
Publisher:
ISBN:
Category : Economics
Languages : en
Pages : 952
Book Description
Publisher:
ISBN:
Category : Economics
Languages : en
Pages : 952
Book Description
Talent Wants to Be Free
Author: Orly Lobel
Publisher: Yale University Press
ISBN: 0300166273
Category : Business & Economics
Languages : en
Pages : 290
Book Description
Presents a set of positive changes in corporate strategies, industry norms, regional policies, and national laws that will incentivize talent flow, creativity, and growth.
Publisher: Yale University Press
ISBN: 0300166273
Category : Business & Economics
Languages : en
Pages : 290
Book Description
Presents a set of positive changes in corporate strategies, industry norms, regional policies, and national laws that will incentivize talent flow, creativity, and growth.
Approaching Complex Diseases
Author: Mariano Bizzarri
Publisher: Springer Nature
ISBN: 3030328570
Category : Medical
Languages : en
Pages : 493
Book Description
This volume – for pharmacologists, systems biologists, philosophers and historians of medicine – points to investigate new avenues in pharmacology research, by providing a full assessment of the premises underlying a radical shift in the pharmacology paradigm. The pharmaceutical industry is currently facing unparalleled challenges in developing innovative drugs. While drug-developing scientists in the 1990s mostly welcomed the transformation into a target-based approach, two decades of experience shows that this model is failing to boost both drug discovery and efficiency. Selected targets were often not druggable and with poor disease linkage, leading to either high toxicity or poor efficacy. Therefore, a profound rethinking of the current paradigm is needed. Advances in systems biology are revealing a phenotypic robustness and a network structure that strongly suggest that exquisitely selective compounds, compared with multitarget drugs, may exhibit lower than desired clinical efficacy. This appreciation of the role of polypharmacology has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity. Integrating network biology and polypharmacology holds the promise of expanding the current opportunity space for druggable targets.
Publisher: Springer Nature
ISBN: 3030328570
Category : Medical
Languages : en
Pages : 493
Book Description
This volume – for pharmacologists, systems biologists, philosophers and historians of medicine – points to investigate new avenues in pharmacology research, by providing a full assessment of the premises underlying a radical shift in the pharmacology paradigm. The pharmaceutical industry is currently facing unparalleled challenges in developing innovative drugs. While drug-developing scientists in the 1990s mostly welcomed the transformation into a target-based approach, two decades of experience shows that this model is failing to boost both drug discovery and efficiency. Selected targets were often not druggable and with poor disease linkage, leading to either high toxicity or poor efficacy. Therefore, a profound rethinking of the current paradigm is needed. Advances in systems biology are revealing a phenotypic robustness and a network structure that strongly suggest that exquisitely selective compounds, compared with multitarget drugs, may exhibit lower than desired clinical efficacy. This appreciation of the role of polypharmacology has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity. Integrating network biology and polypharmacology holds the promise of expanding the current opportunity space for druggable targets.